Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Akso Health Group from 31 Mar 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Akso Health Group quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 31 Mar 2016 to 30 Sep 2025.
  • Akso Health Group Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2025 was $11,128,627, a 88% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Akso Health Group Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,128,627 -$80,238,706 -88% 30 Sep 2025 6-K 10 Feb 2026 2026 Q2
Q1 2025 $176,229,874 +$91,055,857 +107% 31 Mar 2025 6-K 10 Feb 2026 2026 Q2
Q3 2024 $91,367,333 +$81,136,007 +793% 30 Sep 2024 6-K 10 Feb 2026 2026 Q2
Q1 2024 $85,174,017 +$75,981,314 +827% 31 Mar 2024 6-K 10 Feb 2026 2026 Q2
Q3 2023 $10,231,326 +$240,765 +2.4% 30 Sep 2023 6-K 28 Mar 2025 2025 Q2
Q1 2023 $9,192,703 -$12,732,619 -58% 31 Mar 2023 20-F 14 Aug 2025 2025 FY
Q3 2022 $9,990,561 30 Sep 2022 6-K 03 Jan 2024 2024 Q2
Q1 2022 $21,925,322 +$6,796,603 +45% 31 Mar 2022 20-F 14 Aug 2025 2025 FY
Q1 2021 $15,128,719 +$4,203,511 +38% 31 Mar 2021 20-F 30 Jul 2024 2024 FY
Q1 2020 $10,925,208 -$10,789,574 -50% 31 Mar 2020 20-F 14 Jul 2023 2023 FY
Q1 2019 $21,714,782 -$110,907,685 -84% 31 Mar 2019 20-F 28 Jul 2021 2021 FY
Q1 2018 $132,622,467 +$113,390,192 +590% 31 Mar 2018 20-F 14 Aug 2020 2020 FY
Q1 2017 $19,232,275 +$11,413,339 +146% 31 Mar 2017 20-F 14 Aug 2020 2020 FY
Q1 2016 $7,818,936 31 Mar 2016 20-F 31 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.